Eugene Park
Verkoop & Marketing bij MEI PHARMA, INC.
Profiel
Eugene Park is currently working as the Vice President-Marketing at MEI Pharma, Inc. Prior to this, he held the position of Head-Marketing at Immunomedics, Inc. from 2018 to 2019 and at Halozyme Therapeutics, Inc. from 2019 to 2020.
He also served as the Vice President-Marketing at Coherus BioSciences, Inc. Mr. Park completed his undergraduate degree at Massachusetts Institute of Technology and holds an MBA from Columbia Business School.
Actieve functies van Eugene Park
| Bedrijven | Functie | Begin |
|---|---|---|
| MEI PHARMA, INC. | Verkoop & Marketing | 01-07-2021 |
Eerdere bekende functies van Eugene Park
| Bedrijven | Functie | Einde |
|---|---|---|
| COHERUS BIOSCIENCES, INC. | Verkoop & Marketing | 01-06-2021 |
| HALOZYME THERAPEUTICS, INC. | Verkoop & Marketing | 01-01-2020 |
| IMMUNOMEDICS, INC. | Verkoop & Marketing | 01-03-2019 |
Opleiding van Eugene Park
| Columbia Business School | Masters Business Admin |
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
